Medicare Enrolled
Dr. Patrick Allan, M.D.
Pulmonary Disease · Dayton, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Allan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Allan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Allan
Dr. Patrick Allan is a pulmonary disease specialist in Dayton, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Allan performed 3,335 Medicare services across 2,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Allan received a total of $8,963 from 43 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Allan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in OH
$8,963 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,335
Medicare services
Top 3% in OH for pulmonary disease
2,363
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~176 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,034 | $63 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $93 | $160 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
275 | $162 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
245 | $90 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
138 | $60 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $119 | $240 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
130 | $12 | $25 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
129 | $28 | $112 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
126 | $41 | $125 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
125 | $40 | $125 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
101 | $25 | $55 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $38 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
65 | $72 | $150 |
| Ultrasound scan of chest An imaging test that uses sound waves to create pictures of the structures inside the chest. |
53 | $41 | $150 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
45 | $52 | $392 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $129 | $300 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
27 | $36 | $120 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $94 | $150 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
26 | $65 | $105 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
24 | $209 | $325 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
23 | $129 | $1,267 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
21 | $6 | $73 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
16 | $155 | $250 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
13 | $98 | $630 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
12 | $9 | $120 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
11 | $51 | $196 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,963
Total received (2018-2024)
Avg $1,280/year across 7 years
Top 18% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,808 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,708
2023
$766
2022
$1,120
2021
$1,110
2020
$875
2019
$2,540
2018
$844
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$833
Regeneron Healthcare Solutions, Inc.
$179
GlaxoSmithKline, LLC.
$145
Inspire Medical Systems, Inc.
$128
Grifols USA, LLC
$114
AstraZeneca Pharmaceuticals LP
$85
GENZYME CORPORATION
$53
Pulmonx Corporation
$43
JAZZ PHARMACEUTICALS INC.
$28
PFIZER INC.
$24
Philips North America LLC
$21
Insmed, Inc.
$19
Baxter Healthcare
$19
Takeda Pharmaceuticals U.S.A., Inc.
$16
Top 3 companies account for 67.8% of 2024 payments
All-time payments by company (2018-2024) ›
Pulmonx Corporation
$1,724
GlaxoSmithKline, LLC.
$1,553
AstraZeneca Pharmaceuticals LP
$1,073
INTUITIVE SURGICAL, INC.
$833
Boehringer Ingelheim Pharmaceuticals, Inc.
$470
Genentech USA, Inc.
$418
Grifols USA, LLC
$350
Insmed, Inc.
$262
Regeneron Healthcare Solutions, Inc.
$199
Takeda Pharmaceuticals U.S.A., Inc.
$187
Sunovion Pharmaceuticals Inc.
$176
Philips Electronics North America Corporation
$149
Actelion Pharmaceuticals US, Inc.
$138
GENZYME CORPORATION
$131
JAZZ PHARMACEUTICALS INC.
$131
Inspire Medical Systems, Inc.
$128
Intuitive Surgical, Inc.
$121
Amgen Inc.
$112
United Therapeutics Corporation
$99
Electromed, Inc.
$78
Teva Pharmaceuticals USA, Inc.
$75
PFIZER INC.
$71
Jazz Pharmaceuticals Inc.
$59
Baxter Healthcare
$45
E.R. Squibb & Sons, L.L.C.
$41
CSL Behring
$36
Novartis Pharmaceuticals Corporation
$33
Circassia Pharmaceuticals Inc
$27
Breathe Technologies, Inc.
$23
Mallinckrodt Hospital Products Inc.
$21
Philips North America LLC
$21
Nabriva Therapeutics, plc
$18
Shionogi Inc
$18
MAYNE PHARMA INC.
$18
Biogen, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Advanced Respiratory, Inc
$15
Allergan, Inc.
$14
Shire North American Group Inc
$13
Mylan Specialty L.P.
$13
kaleo, Inc.
$12
Merck Sharp & Dohme Corporation
$11
Mallinckrodt Enterprises LLC
$11
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
(2929) Philips Circuits · (5844) Accessories and Disp · (8685) OEM Other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AVYCAZ · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · Fetroja · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · JANUVIA · LONHALA MAGNAIR · Life2000 Ventilation System · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · PAXLOVID · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SMARTVEST · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · XOLAIR · XYREM · XYWAV · Xenleta · Xolair · YUPELRI · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
32
Per 100K population
6.0
County median income
$64,403
Nearest hospital
KETTERING HEALTH DAYTON
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Allan is a clinical cardiology specialist, with above-average Medicare volume (top 3% in OH), with low-engagement industry engagement in the top 18% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Allan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Allan performed 1,034 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Allan receive payments from pharmaceutical companies?
Yes. Dr. Allan received a total of $8,963 from 43 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Allan's costs compare to other pulmonary diseases in Dayton?
Dr. Allan's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Allan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Dayton
Browse pulmonary diseases in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in OH
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in OH
Which OH pulmonary diseases receive the most from drug and device companies.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology